USE OF FXR, PPAR ALPHA AND LXR ALPHA ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION

摘要

PPROBLEM TO BE SOLVED: To improve the disorders of the skin and mucous membranes that have a disrupted or dysfunctional epidermal barrier. PSOLUTION: The disorders of the skin and mucous membranes that have the disrupted or dysfunctional epidermal barrier are treated or prevented by topical application of compounds that are either activators of farnesoid X receptor, activators of peroxisome proliferator-activated receptor , and oxysterol activators of the LXR receptor. The same compounds are also effective in treating disorders of epidermal differentiation and proliferation. PCOPYRIGHT: (C)2005,JPO&NCIPI